Septanest Injection 1/200,000
Articaine Hydrochloride 40mg · Epinephrine Tartrate 0.009mg
Prescription medication · Combination
Shinwon Dental Co., Ltd.
MFDS item code 200308020 · Approved 2003.02.12 · Insurance code 658300030
Pain control through dental local anesthesia (infiltration and nerve block)
Local anesthesia, infiltration anesthesia, and conduction anesthesia methods are used to reduce pain during dental procedures. These anesthetics effectively numb the painful area, providing a comfortable treatment environment. Local anesthesia is applied directly to a specific area to block pain, infiltration anesthesia allows the injected solution to penetrate into the tissue, numbing a wider area, and conduction anesthesia injects the anesthetic along a nerve to alleviate pain in a broad area. These methods safely manage pain and facilitate smooth dental treatment.
Administer by local or regional injection into the oral mucosa. Perform an aspiration test to ensure that the drug is not injected into a blood vessel. The injection rate must not exceed 1mL per minute. Adults The recommended doses for routine procedures are shown in Table 1. The actual dose used is determined according to the type and extent of the surgical procedure, depth of anesthesia, degree of muscle relaxation, and patient's condition. In all cases, administer the minimum dose needed to achieve the desired result. Do not exceed 7mg of articaine hydrochloride per kg of body weight. The maximum dose for healthy adults weighing 70kg or more is 500mg. [Table 1] The recommended doses are for guidance only. Infiltration: 0.5~2.5mL, total dose of articaine hydrochloride 20~100mg Nerve block: 0.5~3.4mL, total dose of articaine hydrochloride 20~136mg Oral surgery: 1.0~5.1mL, total dose of articaine hydrochloride 40~204mg
Age 4 years and older (or body weight 20 kg or more): The maximum dose of articaine hydrochloride must not exceed 5 mg per kg of body weight.
This medication should be administered carefully to avoid accidental injection into the bloodstream. Injection into blood vessels can result in the rapid spread of the drug throughout the body, leading to serious side effects. Patients with hypertension or diabetes should use this drug cautiously as there may be a risk of tissue necrosis in the localized area. Patients with allergies to this drug or its components, certain heart diseases, liver diseases, kidney diseases, epilepsy, children under 4 years old, etc., should not use this drug. Patients taking anticoagulants or antiplatelet drugs may have an increased risk of bleeding and should be monitored. Patients with cardiovascular diseases may be affected in heart function due to the epinephrine component present in this drug, thus requiring strict observation by healthcare professionals. Patients with a history of stroke are advised to postpone treatment due to the risk of recurrence. Patients with impaired liver or kidney function, elderly patients, and those with uncontrolled diabetes should have their dosage adjusted and be closely monitored. Patients with asthma or sensitivity to sulfites should be cautious as they may experience allergic reactions or worsening asthma. This drug can interact with various medications, so patients should inform their healthcare provider about any medications they are taking. Use only when necessary during pregnancy and with caution during breastfeeding. After receiving this drug, dizziness or visual disturbances may occur, so caution is needed when driving or operating machinery. In case of overdose, serious side effects related to the nervous system, respiratory system, and cardiovascular system may occur, necessitating immediate medical attention. Before use, it is essential to check the patient's allergy history and past medical history, and avoid administration if there is an infection at the injection site. After use, it is advisable to refrain from eating until sensation returns to normal at the injection site. This drug requires that aspiration tests be carefully performed to ensure that the injection needle does not enter a blood vessel, and any unusual symptoms should be monitored while communicating continuously with the patient. Once opened, the cartridge should not be reused, and it must not be mixed with other drugs.
Gingivitis, allergy, anaphylaxis, anaphylactoid reaction, hyperesthesia, anxiety, euphoria, neuralgia, sensory loss, numbness, hyperesthesia, sensory abnormality, taste disorder, loss of taste, abdominal pain, temperature hypersensitivity, headache, burning sensation, facial nerve disorder, Horner's syndrome, drowsiness, nystagmus, sensory abnormality after mandibular or inferior alveolar nerve block, double vision, visual impairment, ptosis, mydriasis, exophthalmos, auditory hypersensitivity, tinnitus, bradycardia, tachycardia, palpitations, hypotension, hypertension, facial flushing, localized congestion, vasodilation, vasoconstriction, bronchospasm, asthma, respiratory distress, voice disorders, tongue swelling, lip swelling, gum swelling, stomatitis, glossitis, nausea, vomiting, diarrhea, shedding of gingival and oral mucosal tissue, ulcer, dysphagia, swelling of the cheeks, sore tongue, rash, itching, angioedema, urticaria, erythema, hyperhidrosis, cervical pain, muscle fasciculation, injection site pain, injection site shedding, necrosis, fatigue, weakness, chills, localized swelling, heat sensation, cold sensation, presyncope, syncope, headache, restlessness, confusion, disorientation, dizziness, tremor, stupor, severe CNS depression, loss of consciousness, coma, convulsions, speech disorder, vertigo, balance disorder, mydriasis, blurred vision, accommodation disorder, pallor, apnea, slow breathing, hyperventilation, yawning, respiratory depression, cardiac arrest, myocardial depression
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a sealed container to prevent air ingress, and it should be kept at room temperature between 1 and 25 degrees Celsius. It is also important to store it in a dark place to avoid exposure to light.
A cartridge-type ampoule filled with a colorless, transparent liquid
1.7 mL x 50 cartridges
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Articaine Hydrochloride 40mg · Epinephrine Tartrate 0.009mg
Prescription medication · Combination
Shinwon Dental Co., Ltd.
Articaine Hydrochloride 40mg · Epinephrine Tartrate 0.018mg
Prescription medication · Combination
Shinwon Dental Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.